CareView Communications Inc 8-K

What Happened
CareView Communications, Inc. (CRVW) announced in an 8-K filed April 2, 2026 that the company, its wholly owned borrowing subsidiary (CareView Communications, Inc. as Borrower), lender PDL Investment Holdings, LLC (as assignee of PDL BioPharma, Inc.), CEO Steven G. Johnson and director Dr. James R. Higgins entered into a Fourteenth Amendment to the Credit Agreement on March 30, 2026. The amendment specifically extends the Credit Agreement’s maturity date to June 30, 2026. The Credit Agreement originally dated June 26, 2015 has been amended multiple times; the new amendment is filed as Exhibit 10.46 to the 8-K.

Key Details

• Amendment date: March 30, 2026; 8-K filed April 2, 2026.
• New maturity date: June 30, 2026 (extension of the loan maturity).
• Parties: CareView (and its borrowing subsidiary), PDL Investment Holdings, LLC (lender), Steven G. Johnson (CEO) and Dr. James R. Higgins (director) are signatories to the amendment.
• The filing also notes the creation/continuation of a direct financial obligation related to the amended credit agreement (Item 2.03) and includes the amendment as Exhibit 10.46.

Why It Matters
An extension of the loan maturity gives CareView more time before the debt comes due, which affects the company’s near-term financing timeline and liquidity needs. For investors, this is a material financing development — it is not an earnings item but relates to the company’s capital structure and obligations. Review the company’s upcoming filings (quarterly results, liquidity disclosures) to see how this amendment fits into overall cash position and financing plans.